On Dec 19, 2025, the US Food and Drug Administration (FDA) announced a major milestone by qualifying total hip bone mineral density (BMD), assessed by dual-energy X-ray absorptiometry, as a surrogate ...

CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity and ...

March 16, 2012 — The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) today recommended that the osteoporosis drug strontium ranelate (Protelos/Osseor, Les ...

On Monday, the Food and Drug Administration issued a new draft guidance that requires drug manufacturers to conduct long-term nonclinical bone quality studies for osteoporosis treatments. The agency ...

The FDA Biomarker Qualification Program approved changes in hip bone mineral density (BMD) after treatment to serve as a surrogate endpoint in place of bone fractures in anti-osteoporosis drug ...

For millions of women who have the bone-thinning disease osteoporosis, researchers are reporting that Fosamax, the drug most commonly used worldwide to improve bone density and prevent fractures, can ...

In A Nutshell An existing osteoporosis medication (PTH) reduced chronic back pain in three mouse models of spinal ...

One expert says a new osteoporosis drug may not be as exciting as many believe. May 8, 2007 — -- One might be convinced it's a glorious week for our aging bones. The Food and Drug Administration ...

Osteoporosis causes brittle, porous bones. Typically, Original Medicare (Part A and Part B) covers most outpatient screenings, treatments, and inpatient surgical procedures for osteoporosis. A person ...

Amgen is running a number of studies of its obesity drug, MariTide.